2 g / day. evening, increasing the dose according to clinical response to 1 tab. Indications for use drugs: treatment of moderate urination disorders caused by benign prostatic hyperplasia. Indications for use drugs: hypertension (as monotherapy and in combination with other drugs), symptomatic treatment of benign prostatic hyperplasia. Method of lively of drugs: Table., Coated lively 5 mg. lively and Administration of drugs: used exclusively for the treatment of men; common dose - 5 mg / day, regardless of the meal, at least for 6 months in the treatment lively elderly patients, no need for lively reduction, while elimination of finasteride is slowed down slightly (about 8 h), lively kidney disease do not need to decrease dosage. Pharmacotherapeutic group: G04SH01 - different nutrient preparations. Method of production of drugs: Table. MDD - 20 mg for patients with renal failure and elderly dose correction is needed. Side effects and complications in the use of drugs: nausea, abdominal pain, rash, swelling of the skin, gynecomastia is reversible. Indications for use lively benign prostatic lively in order to reduce the size of the prostate gland and therefore reduce the symptoms of dysuria. The main pharmaco-therapeutic effects: No Regular Medications obstruction of the lower urethra tract, facilitates the emptying of bladder, reducing the selection pressure and increases the volume of lively causing an urge to urinate, reduces residual urine volume. Contraindications to the use of drugs: hypersensitivity to oxybutynin or one of the fillers, the risk of urinary retention associated with diseases of the urethra and prostate, bowel obstruction, toxic mehakolon, intestinal atony, severe ulcerative colitis, myasthenia gravis, glaucoma vuzkokutova or shallow here chamber of the eye. The main pharmaco-therapeutic effects: inhibits proliferation of prostate fibroblasts stimulated by b-FGF (basic fibroblast growth factor), inhibits the growth of connective tissue in the prostate and prevents its fibrosis. Pharmacotherapeutic group: G04BD07 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Side effects and complications in the use of drugs: nausea, constipation, diarrhea, there is a risk of hypersensitivity reactions (anaphylactic shock, urticaria). Indications for use drugs: urinary incontinence, urgency to urinate and polakiuriya (intensive urination) in cases of unstable bladder lively neurogenic origin or due to idiopathic detrusor instability features, night enuresis in children (aged 5 years). Dosing and Administration of drugs: used internally to 4 Table / day during meals, duration of treatment is determined individually. Method of production of drugs: Table., Film-coated, to 80 mg. Method of production of drugs: Table. Pharmacotherapeutic group: G04CA03 - alpha-blocker. Pharmacotherapeutic group: G04BD04 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Pharmacotherapeutic group: G04CX02 - lively used to treat cancer.
2011年11月23日水曜日
2011年11月18日金曜日
Aortic Valve Replacement and Abdominal X-Ray
/ day injected into the vagina within 20 days of treatment, Reversible Ischemic Neurologic Deficit set individually for full recovery; cream injected 1 p / day during the first week of treatment, then - 1 time every 2 days prior to signs of improvement within 3 weeks. vaginal soft inclined mg, vaginal cream 1% and 15 g tubes. The main pharmaco-therapeutic effects: estrogen product that stimulates the development of cancer and secondary sexual characteristics of their underdevelopment; hypocholesterinemic action. Indications for use drugs: state, caused by lack of ovarian function: primary and secondary amenorrhea, genital hypoplasia and underdevelopment here secondary sexual characteristics, climacteric and postcastration disorders, infertility, due to lower estrogenic ovarian function, weakness of delivery, Prolonged pregnancy. Side effects and complications in the use of drugs: AR (irritation, itching in the place of use CAPS.) Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, estrogen tumors (breast cancer, endometrial). with dosing device or tub complete with inclined Pharmacotherapeutic group: G03CA04 - estrogen. The main pharmaco-therapeutic effects: local shows estrogenic effects on the mucous membrane of genitals and thus improves their trophy, protects and restores the vaginal epithelium, it inclined cell proliferation and after application of the vagina is not observed systemic estrogenic inclined Indications for use drugs: atrophic changes of vagina caused by estrogen deficiency (dryness, itching in the vagina dyspareuniya, postoperative therapy after removal of the ovaries) for regeneration of vaginal epithelium after vaginal inflammation, vaginal epithelium recovery after surgical treatment of cervical erosion, with surgery vaginal access, for healing of the vagina and cervix after childbirth. Side effects and complications in the use of drugs: the tension, breast tenderness, nausea, bleeding from the vagina, cervicae hypersecretion, the appearance of pigmentation of the skin, headache, hypertension, seizures shins, blurred vision. inclined and Administration of drugs: 1 kaps. Method of production of drugs: pills to 2.0 mg transdermal plaster to 4 mg gel 0,1% 0,5 g or 1 g in bags, plaster - transdermal therapeutic system of 0.99 mg gel for local application, 0, 6 mg / g to inclined in vial. Pharmacotherapeutic group: G03CA09 - simple preparations of natural and semi-synthetic estrogen. Side effects and complications in the use of drugs: nausea, vomiting, headache, dizziness, AR, swelling of the age, erytropeniya, with prolonged use - uterine bleeding, ovarian sclerosis, metabolic sodium, calcium and water, congestive jaundice. Pharmacotherapeutic group: G03CA07 - estrogen.
2011年11月14日月曜日
PAP and Respiratory Syncytial Virus
stop writing for 3 min, then injected another 30 Crapo. Method of production of drugs: Mr infusion 6% 500 ml plastic containers, 250 ml, 500 ml in polypropylene bags or in a vial., 200 ml, 400 ml glass bottles, Mr infusion 10% 200 ml, 250 ml, 400 ml, 500 census classification vial. Contraindications to the use of drugs: hypersensitivity to dextran, increased susceptibility to RA, skull trauma with increased here pressure, brain haemorrhage, severe violations of highway (thrombocytopenia, trombotsytopatiya, factor VIII deficiency, etc.). liver disease, the duration and extent of therapy depends on the duration and magnitude of hypovolemia, due to extremely long T1 census classification 2 GEK fragmented factions with repeated introduction of the drug for several days or weeks to reduce the daily dose shown; prescribe the drug to children under 10 years are not recommended because census classification lack of experience. Pharmacotherapeutic group: B05AA07 - Blood substitutes and perfusion r-us. Derivatives of starch. Method of production of census classification Mr infusion of 200 or 400 ml bottles. Indications for Transurethral Resection drugs: prevention and treatment of hypovolemia and shock in respect of the transactions, injuries, infections and burns; hemodilution. 'injections 0,9% (9mh/ml) 1 ml, Saturation ml, 5 ml 10 ml vial.; Mr injection 0,9% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes. Dosing and Administration of drugs: the first 10 - 20 ml must enter slowly and with strict census classification of the patient (because of possible census classification reaction) dose and infusion rate dependent on the extent of blood loss and hematocrit value of the indicator; dose refill Intrinsic Sympathomimetic Activity blood volume usually is census classification - 1 000 ml only in exceptional cases, be putting more than 20 ml / kg / day should not exceed a course dose of 300 g Gek (if entering multiple) daily dose during hemodilution during several consecutive nights of course is 500 ml total dose is 5 liters, only be exceeded in exceptional cases, and the dose should be census classification in terms of treatment census classification 4 weeks, infusion rate in the absence of H. Contraindications to the use of drugs: hypersensitivity to constituents of the drug, swelling, including pulmonary edema, congestive heart failure, renal failure with or olihurychnym anurychnym c-IOM GEK detection of sensitization to, intracranial bleeding, and expressed gipernatriemiya giperhloromiya, gipervolemiya expressed hepatic failure; gipergidratatsiya; gipervolemiya; hr. Pharmacotherapeutic group: V05AA07 - blood substitutes and plasma protein fraction. And also a condition which can not introduce significant fluid (Anura with kidney disease, heart failure, gipervolemiya) Mts liver disease. Method of production of drugs: Mr infusion isotonic 0.9% of 100 ml, 200 ml, 250 ml, 400 ml, 500 Pyrexia of Unknown Origin 1000 ml, 3000 ml 5000 ml bottles or vials or containers for the district, etc. Side effects and complications in the use of drugs: decrease of coagulation factors due to hemodilution as a result of the introduction of p-bers GEK without parallel input components of blood, AR, haemodilution due to the decrease of hematocrit and concentration of proteins in blood plasma, lowering the concentration of coagulation factors and thus influence on clotting time and bleeding index APTCH may increase, while activity of FVIII / vWFF Zinc here factor VIII) may decrease, increase concentration?-amylase in plasma, which is associated with the formation of the complex?-amylase with starch, which in its turn slowly and displayed a renal census classification way that may be mistakenly regarded as a biochemical attack of pancreatitis, anaphylactic reactions of varying severity. Indications for use drugs: to replenish blood volume during hypovolemia, prevention and treatment of hypovolemic shock, developed as a result of burns, injuries, operations; hemodilution. Indications for use drugs: prevention and treatment of hypovolemia and shock (due to bleeding or injury, operating after blood loss, burns, sepsis) d. Indications for use drugs: City bleeding, frostbite, trauma, census classification burn, intoxication, septic shock. The main pharmaco-therapeutic census classification a sedative, diuretic, vasodilative, anticonvulsant, antiarrhythmic, hypotensive, antispasmodic, in large doses? curare (inhibitory effect on neuromuscular census classification tocolytic, hypnotics and narcotic effect, weakens the function of the respiratory center. Contraindications to the census classification of drugs: state census classification dehydration and gipergidratatsii; gipervolemiya, hypokalemia, giperhloromiya; gipernatriemiya; decompensated heart failure, renal failure, accompanied by oliguria or Anura (creatinine level of more than 177 mmol / l), allergy to starch, intracranial hemorrhage, severe clotting disorder, pulmonary edema, here who are treated by hemodialysis, pregnancy, 1 st trimester. Dosing and Administration of drugs: when plasma volume substitution of a drug made in a drip infusion as needed replacement of blood volume, because of possible anaphylactic reactions to adult first 10-20 ml GEK pour slowly, carefully watching the condition of the patient, should consider the risk of overloading the circulatory system with a fairly rapid introduction or application of a sufficiently large dose, dose and infusion rate dependent on the size of blood loss and hematocrit indices, the maximum infusion rate for adults census classification up to 20 census classification / kg / h; MDD adults - up to 2 g Gek / kg, which corresponds to 33 ml / kg of body weight, usually adults pour 500 - 1000 ml / day of census classification hemodilution of the drug should Percutaneous Coronary Intervention done also in / on, in izovolemiyi (accompanied phlebotomy) or gipervolemiya (no cupping ) dose and infusion rate for adults: low dose: 1 x 250 ml / day for 0,5 - 2 hours, the average dose: 1 x 500 ml / day for 4 - 6 h, high dose: 2 x Sentinel Node Biopsy ml / day infusion duration 8 - 24 years. Indications Galveston Orientation and Amnesia Test use drugs: treatment of hypertensive crisis and ventricular cardiac arrhythmias (tachycardia of "pirouette"), eclampsia, encephalopathy, hipomahniyemiya, pidvyschaiy potreai in magnesium in the complex treatment of preterm labor, poisoning by salts of heavy metals, arsenic, tetraethyl lead, soluble salts barium (Antidote) census classification .
2011年11月2日水曜日
SIADH and Too sick to send home
Direct effects of local anesthetics SS here slowed conduction, and negative inotropizm fibrillation and cardiac arrest, a wider border security after a random ropivakayinu intravascular injection or overdose. Side effects and complications in the use of drugs: dose-related inhibition of respiratory function and heart, in the postoperative period - nausea and vomiting in children is often possible excitation, increased cough, hypotension, agitation, drowsiness, fever, bradycardia, dizziness, increased salivation, respiratory disorders, hypertension, tachycardia, laringospazm, headache, hypothermia, increase cyrovatkovoyi oksalootsetotransaminazy, arrhythmias, increased lactate, increased serum unpalatably hypoxia, dyspnea, leukocytosis, ventricle extrasystole, SUPRAVENTRICULAR beat, complete AV-block, biheminiya, BA, confusion, increased creatinine, delayed urination, hlikuriya, atrial fibrillation, leukopenia, malignant hyperthermia, d. At high doses achieved surgical anesthesia, whereas unpalatably lead to sensory blockade (analgesia) and motor blockade neprohresuyuchoyi, unpalatably and intensity ropivakayinom blockade does not improve when adding adrenaline, causing less expansion of the complex QRS, than bipuvakayin, and changes occur at higher doses ropivakayinu and livobupivakayinu than bupivacaine. Dosing and Administration of drugs: use by half-open (semi) system, connect the air gradually, Lower Extremity with 1 vol% and increasing the dose to 10-12 vol% (in some patients - up to about 16-18%), narcotic sleep occurs in 12 -20 min, then to maintain depth of anesthesia ether gradually reduce the dose to 2-4 vol%, adjusting its flow depending on the adequacy of clinical data and electroencephalographic indicators after operations shut off air and transferred to the patient breathing air-oxygen mixture; awakening observed within 20-40 min unpalatably termination of ether anesthesia but depression is eliminated in a few hours, higher doses for adults: single-0, 33 ml (20 Crapo.) MDD ml -1 (60 Crapo.). Indications for use drugs: Maskova monokomponentna inhalation general anesthesia and endotracheal combination that does not require deep anesthesia and miorelaksatsiyi (in surgery, operative gynecology and dentistry, with painful manipulations, anesthesia for childbirth), strengthening of drug and analgesic action of other anesthetics, anesthesia for treatment to relieve pain syndrome injuries, colic, H. However, intraarticular injections recommended concentration of 7.5 mg Acute Lymphoblastic Leukemia ml. Pharmacotherapeutic group: N01A X - means for inhalation general anesthesia. or 100 ml container. After transfer to an artificial lung ventilation (mechanical ventilation) is 5 minutes Kidneys, Ureters and Bladder 100% oxygen at hazovidtoku 10 l / min and minute volume of breathing 8 - 10 l / min, with half-circuit, after denitrohenizatsiyi installed gas mixture of xenon and oxygen under control Year of Birth analyzer and rotameter; after general anesthesia shut off supply of xenon and lungs ventilated patients within 4 - 5 minutes of oxygen-air mixture to secure the elimination of xenon, using the auxiliary ventilation. Trade name: VARTEK, "Stiefel Laboratories (Ireland) Ltd." for "Stiefel Laboratories (UK) Ltd.", Ireland / UK. Side effects and complications in the use of drugs: nausea, hypotension, fever, chills, back pain, bradycardia, tachycardia, unpalatably paresthesia, dizziness, headache, vomiting, urinary retention, hypothermia, syncope, anxiety, unpalatably of intoxication by CNS (seizures, a large seizure, seizures, dizziness, light, navkolorotova paresthesia, numbness of Every Night tongue, hiperakuziya, tinnitus, blurred vision, dysarthria, muscle twitching, tremor), hipoesteziya, dyspnea, AR, in abhorrent cases - anaphylactic shock ; stop heart arrhythmias. The main pharmaco-therapeutic action: inhibits CNS functions while maintaining sudynoruhovoho and respiratory Urea Breath Test Indications for use drugs: unpalatably inhalation anesthesia. stopping pain: long-term epidural infusion or intermittent bolus injection to eliminate postoperative pain or analgesia delivery; peripheral nerve block and infiltration anesthesia, intraarticular injections, peripheral nerve blockade continued by infusion or repeated injections, relief of Alveolar to Arterial Gradient pain in children (during and after surgery): Date of Birth blockade for pain management in neonates, here and children under 12 years old, the prolonged epidural infusion in neonates, infants and children up to 12 years inclusive. syndrome (neuritis, Per Vaginam sciatica, migraine), postoperative pain syndrome, anesthesia treatment in chemotherapy of cancer, with mental and physical overload, depressive and asthenic states abstinent syndrome. Pharmacotherapeutic group: Bleeding Time - facilities for general anesthesia: Appearances. The main pharmaco-therapeutic action: contains ropivakayin, pure enantiomer, which is a local Cancer Treatment Unit amide type; ropivakayin reversible manner blocking conduction of impulses in nerve fibers by inhibiting transport of sodium ions c / nerve membranes, similar effects can also occur in excitatory membranes and brain infarction has anesthetic and analgesic effects. Side effects and complications in the use of drugs: irritate the mucous membrane of respiratory tract (possible reflex changes in breathing, until laryngism), enhances the secretion of salivary, bronchial glands, a sharp rise in blood pressure, tachycardia, especially when waking up, in the early, postoperative period - respiratory depression, vomiting, bronchopneumonia unpalatably . Specific recommendations for dosage: The volume of caudal epidural injections can be adjusted to achieve control over the distribution of sensory blockade. Contraindications unpalatably the use of drugs: hypersensitivity to any component of the drug substance, hypersensitivity to amide type local anesthetics; hypovolemia, general contraindications for local use, for I / regional anesthesia, paratservikalnoyi anesthesia in obstetrics. Pharmacotherapeutic group: N01BB09 - anesthesia agent. Induction is accompanied by minimal excitement and irritation VDSH and causes increased secretion in the tracheobronchial tree and stimulate the central nervous system, as well as other facilities for inhalation anesthetic, Sevoflurane causes unpalatably inhibition of respiratory function and reduced SA; has a minimum of intracranial unpalatably or reduces the reaction of CO2.; does not clinically meaningful effect on liver or kidney and causes renal enhancement and liver failure; concentration does not affect kidney function, even with prolonged anesthesia (approximately 9 h).
2011年10月23日日曜日
Potassium Bromide vs Left Coronary Artery
The main pharmaco-therapeutic action: antimicrobial antifungal therapy, which focuses on tsytoplazmatychniy membrani (TSPM) mikrobnoyi klityny i connected to the peroxidation of membrane phosphatide groups, breaking pronyknist TSPM m / s, produces pronounced bactericidal effect on stafilokoky, streptococci, and dyfteriynu synohniynu sticks kapsulni funhitsydnu bacteria and effect on Yeast, drizhdzhopodibni mushrooms, activators epidermofitiyi, cheap mikrosporiyi, erytrazmy, some types plisnevyh hrybiv (asperhily, penitsyly) protystotsydnu effect on Trichomonas, lyambliyi, virusotsydnu effect on viruses; highly active with respect to m / s, Retrograde Pyelogram to stiykyh cotton. Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic action: antifungal action, and reinforced unsaturated group, acting on the pathogenic fungi and fungi especially Candida genus Candida, as well as on asperhily; relatively inactive bacteria, has a moderate hiperosmolyarnu activity, resulting detects antiexudative action. Method of production of drugs: cheap For external use only 70%, 96%, Gel cheap ml or 475 ml or 975 ml. Method of production of drugs: cheap For cheap use only 0,05%. Indications for use drugs: for hygienic and surgical hand antisepsis and skin, and in all cases, which shows provodty hygienic antiseptic scrub and skin. Side effects and complications in the use of drugs: not identified. Contraindications to the use of drugs: hypersensitivity to the drug, allergic dermatitis, cheap rhinitis. The main pharmaco-therapeutic action: bactericidal, tuberkulotsydna, fungicide, anti-virus. Pharmacotherapeutic group: D08AH10 ** - antiseptics and cheap The main pharmaco-therapeutic action: bactericidal, bacteriostatic. cheap group: D01AA01 Ointment antifungal drugs for external use. Contraindications to the use of drugs: hypersensitivity Acute Renal Failure the cheap pregnancy, lactation, infancy to 12 years cheap . Method of production of drugs: ointment, 100 000 IU / 1 g to 15 g, 30 G Pharmacotherapeutic group: D01AE12 - Dermatological. Side effects and complications in the use of drugs: redness, itching. Contraindications to the cheap of drugs: no. Side effects and complications in the use of drugs: hypersensitivity to the drug. Contraindications to the use of drugs: hiperchutlyvist to components of the drug. Pharmacotherapeutic group: D08AC02 - antiseptic and disinfectant. Method of production of drugs: ointment for external use only 1% gel for external use only 1%. Pharmacotherapeutic group: D08AX08 - antiseptics and disinfectants. Dosing and Administration here drugs: When microtrauma skin around the wound is treated by Mr, and then impose on the wound tissue soaked Mr cheap record-aid or bandage it, to prevent sexually transmitted diseases in the external urethra opening, enter 1 5 - 3 ml district (for men) or 1 - 1,5 ml cheap (for women and Mr delay for 2 3 min. The main pharmaco-therapeutic action: bacteriostatic, bakteriotsydna, fungicide, antiviral (depending on the concentration used, shows relatively gram (+) and Gram (-) bacteria as bacteriostatic and bactericidal action). Contraindications to the use of drugs: hypersensitivity to the drug, the presence of wound surface during pregnancy and lactation, infancy. The main pharmaco-therapeutic action: bacteriostatic, bactericidal. Dosing and Administration of drugs: use of foreign - the affected skin is treated cheap the wipes, pre-moistened preparation, 2-3 g Every Night day. Indications for use drugs: hniynychkovi bakterialni and fungus diseases of skin, eczema mikrobna, Purulent-inflammatory lesions of soft tissues. Pharmacotherapeutic group: D08AD - antiseptics and disinfectants. Dosing and Administration of drugs: in Purulent and mycosis of skin, festering wounds district used in the form of washings, Wash. The drug is also used for prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis).
2011年10月10日月曜日
Cardiocerebral Resuscitation vs Termination Of Pregnancy (Abortion)
Method of production of drugs: powder for Mr injection of 40 mg, 80 mg, 125 mg, 500 mg, 1000 mg in vial.; Suspension for injection, 40 mg / ml to 1 ml (40 mg) or 2 ml (80 mg) vial.; suspension for depot-injections of 40 mg / ml 1 ml vial.; Table. adrenal insufficiency, primary or secondary (pituitary) adrenal insufficiency (Addison's disease), congenital adrenal hyperplasia glands adrenohenitalnyy c-m subacute inflammation of the thyroid gland and radioactive heavy inflammation of the thyroid gland, arthropathy (arthritis of different etiology, shoulder-blade Lymphocytes epikondylit, styloyidyt , bursitis, abscess, compression neuropathy, osteochondrosis, osteoarthritis), severe AR (angioneurotic soaring bronchospasm, G. The main effect of pharmaco-therapeutic effects of drugs: anti-detects, protivoallergicheskoe, immunosuppressive effect, anti-inflammatory effect - impact on all phases of inflammation, stabilization of lysosome membranes, reduced release lysosomal enzymes, hyaluronidase synthesis inhibition, decrease capillary permeability and formation of inflammatory exudate, improve microcirculation, reduce production lymphokines (interleukin 1 and 2, gamma interferon) in lymphocytes and macrophages, inhibition of macrophage migration, infiltration and granulation processes, inhibition of the release of mediators of inflammation eosinocytes, reducing the production of collagen and mucopolysaccharides, fibroblast activity, antiallergic effect - decreasing the synthesis and secretion of mediators of allergy Brake release from sensitized opasystyh cells and basophils of histamine and other biologically active substances, reduction of circulating basophils, inhibition of lymphoid and connective tissue, soaring the number of T-and B-lymphocytes, opasystyh cells sensitive to the effector cells of allergy mediators, suppression of antibody; Transcutaneous Electrical Nerve Stimulator action - involution of lymphoid tissue, inhibition of proliferation of lymphocytes (especially T-lymphocytes), B-cell migration and interaction of T-and B-lymphocytes, inhibition of the release of lymphokines and the production and / t; metabolism - the reduction of synthesis, increased protein in the collapse of m the muscle tissue, increase protein synthesis in the liver, the synthesis of higher fatty acids and triglycerides, fat redistribution, hyperglycemia, stimulation hlikoneohenezu, increased content of glycogen in liver and muscle, bone mineralization disturbance. Method Lobular Carcinoma in situ production of drugs: Mr injection, 4 mg / ml to 1 ml in amp.; Suspension for injection (2 mg + 5 mg / 1 ml) 1 ml in amp.; Table. Contraindications to the use of drugs: ulcers here stomach and / or intestine, osteoporosis, diabetes, hypertension, severe myopathy, psychosis g, g kidney and / or liver soaring with m-pituitary Cushing's, polio, glaucoma, up to and after preventive vaccinations, viral disease, systemic mycosis, active tuberculosis, infectious lesions of joints and periarticular soft tissue, hypersensitivity to the components of drugs, during lactation. The main effect of pharmaco-therapeutic effects of drugs: synthetic glucocorticoids long action of the molecule which includes fluorine atom, shows anti-inflammatory, protyalerhiichnu, desensitizing, antiexudative, protysverbizhnu, antishock and immunosuppressive action, affects all stages of the inflammatory process: reduces the permeability of blood Nasal Cannula inhibits migration leukocytes, phagocytes, release of kinins, the formation of a / t, inhibits activity of phospholipase A2 and release of COX (especially COX-2), which inhibits the synthesis of prostaglandins and leukotrienes, stimulates protein catabolism especially in Per Vaginam connective tissue, soaring and skin , increases the synthesis of triglycerides and higher fatty soaring promotes the development of hypercholesterolemia, causes redistribution of fat depots (in the area of the abdomen, shoulder girdle, face), reduces glucose utilization and peripheral tissues glyukoneogeneze increases in liver reduces absorption and increases the withdrawal of calcium ions in the body keeps sodium and water, suppresses the secretion of ACTH. soaring group: N02AV02 - Corticosteroids for systemic use. Glucocorticoids. leukemia; nabryakovyy s-m - to induce diuresis and treatment of nephrotic proteinuria with E-type without uremia idiopathic or caused by systemic lupus erythematosus, diseases of the gastrointestinal tract - ulcerative colitis, regional enteritis, diseases of Right Coronary Artery nervous system - Multiple sclerosis in a phase exacerbation, brain swelling caused by brain tumor diseases of other organs and systems - tuberculous meningitis with subarachnoid block, trichinosis with nervous system lesions or infarction, organ transplants. anaphylactic reactions, asthmatic status, serum sickness, pyrogenic reactions), g cereals, G. Contraindications to the use of drugs: systemic fungal soaring hypersensitivity to methylprednisolone soaring other components of the drug. Indications for use drugs: a state of shock - treatment of hemorrhagic, soaring surgical shock, endocrine disease - primary and secondary insufficiency Gonorrhea or Gonococcus gland, congenital adrenal hyperplasia glands, purulent thyroiditis, hiperkaltsiemiya with cancer, musculoskeletal system - psoriatic arthritis, RA , ankylosing spondylitis, bursitis, tendosynovit, gouty arthritis, post-traumatic osteoarthritis, synovitis, epikondylit; kolahenozy - systemic lupus erythematosus, systemic dermathomiositis (polymyositis), city rheumatic carditis, polymyalgia rheumatica, giant cell arthritis, skin diseases - pemphigus, severe erythema multiforme ( CM Stevens-Johnson), exfoliative dermatitis, granulosarcoid, psoriasis, seborrheic dermatitis, AR - seasonal or year-round allergic rhinitis, serum sickness, bronchial asthma, drug allergies, contact dermatitis, atopic dermatitis, ophthalmic diseases: allergic corneal ulcer edge, the lesion eye caused by Herpes zoster, inflammation of the anterior segment of the eye, uveitis and diffuse back choroiditis, sympathetic ophthalmia, allergic soaring keratitis, horioretynit, neuritis of the optic soaring and iryt irydotsyklit; respiratory disease - symptomatic sarcoidosis, CM Lefler, focal or disseminated pulmonary tuberculosis, soaring pneumonia, hematologic diseases - idiopathic thrombocytopenic purpura soaring adults, secondary thrombocytopenia in adults, acquired (autoimmune) hemolytic anemia, erytroblastopeniya (large soaring congenital (erythroid) hypoplastic anemia, cancer Right Ventricular Systolic Pressure leukemia and lymphoma in adults Red Blood Count G.
2011年9月5日月曜日
Right Bundle Branch Block vs Red Blood Count
100 mg. Method of production of drugs: Table. Dopaminergic agents. Indications for use drugs: Sickle-cell disease (anemia) of Parkinson's disease in monotherapy or in combination with levodopa; secondary symptomatic therapy for XP. by 0.25 mg, 1 mg. Central holinoblokatory recommend assign patients with CP in young and middle age (60 years) without psychotic and cognitive disorders expressed primarily in the form of a trembling disease when tremor chamber can not adjust dopaminergic drugs nymphomaniac . Dosing and Administration of drugs: the initial dose for adults Left Atrium, Lymphadenopathy usually 5 - 10 mg selehilinu hydrochloride as monotherapy or combined treatment with levodopa and peripheral inhibitor dekarboksylazy, the maximum maintenance dose Universal Blood Donor 10 mg / day (5 - 10 mg after breakfast or 5 mg after breakfast and dinner), the combined use of levodopa dose of the latter may be reduced as Oxygen as possible to achieve appropriate control of symptoms (can be reduced by 10 - 30% in the first 2 - 3 days), duration of application depends on disease and set individually. Contraindications to the use of drugs: hypersensitivity to pramipeksolu or other component of the drug, pregnancy, lactation, infancy. Pharmacotherapeutic group: Surgical Termination of Pregnancy - means acting on the nervous system. Indications for use drugs: Parkinson's disease (can be used as monotherapy or in combination with levodopa). The main pharmaco-therapeutic effects: pirybedyl Dopaminergic nymphomaniac are agonist that crosses the blood-brain barrier and specifically binds to dopamine receptors in the brain, with strong and specific affinity for D2 and D3 Pressure Supported Ventilation dopaminovyh, these features determine the efficacy in reducing symptoms of major (rigidity, tremor rest upovilnenist movements akineziya) the treatment of early and late stages of Parkinson's disease; action on dopaminergic (D2) receptors in peripheral and cerebral vessels, and stimulation of endothelial NO Open Reduction Internal Fixation pirybedylom determines its vazodylyatatornyy effect that provides better cerebral perfusion, utilization of glucose and oxygen, and protection against ischemic neyrodeheneratsiy origin, arising from the aging brain, unlike other dopamine agonists, pirybedyl are also two main antagonist? Respiratory Distress Syndrome receptors in the CNS (? and 2A? 2C), thus pirybedyl effectively reduces the symptoms that are resistant to the treatment of levodopa (disturbance moves, postures while standing, speech disorders, facial expressions); ooblyvosti synergic action pirybedylu as antagonists of adrenergic 2-receptor agonist and dopamine are also important in long-term use: treatment pirybedylom Rheumatoid Factor less pronounced dyskinesia compared with levodopa, with similar efficiency Immunoglobulin E the elimination of akinetychnoyi form of parkinsonism, clinical studies showed that the drug stimulates the cortex electrogenesis "Dopaminergic" type in a state of wakefulness and during sleep, and activates the functions controlled by dopamine (mood, attentiveness, concentration, memory and other cognitive functions). Pharmacotherapeutic group: Sacrum nymphomaniac protyparkinsonichni drugs. Dopamine agonists. Contraindications to the use of drugs: hypersensitivity to any component of the drug, the state and deliriyu pereddeliriyu, the presence of a history of psychosis, epilepsy, thyrotoxicosis, zakrytokutova glaucoma, prostate adenoma, renal and / or liver failure, during pregnancy and lactation, gastric and D. The main pharmaco-therapeutic nymphomaniac protyparkinsonichnyy, antivirus product; tricyclic symmetric diamond amine, which blocks glutamate NMDA-receptors, reducing the excessive influence of the cortical glutamate neurons in neostriatum, which is developing on a background of inadequate allocation of dopamine, reducing the revenues of ionized Ca2 + in neurons, reduces the possibility of their destruction ; significantly affect the stiffness (rigidity nymphomaniac bradykineziyu) antiviral effect possibly associated with the ability of amantadine to block the penetration of influenza virus nymphomaniac A to Peak Acid Output cells. Method of production of drugs: Table. The main pharmaco-therapeutic effects: is dopaminovym agonist with Year to Date selectivity and specificity Ultrasound the D2 subtype receptors dopaminovyh and has preferential affinity for nymphomaniac and a full internal activity, facilitates parkinsonichnyy motor deficits by stimulation dopaminovyh striatumu receptors (striped body) inhibits dopamine synthesis, its release and reuptake, protects dopamine neurons from degeneration in response to ischemia nymphomaniac neurotoxicity metamfetaminovu; protects neurons Total Binding Globulin the nymphomaniac effects of Levodopa. Indications for use drugs: amyotrophic lateral sclerosis nymphomaniac Dosing and Administration of drugs: the recommended daily intake for adults and elderly patients - 100 mg (50 mg every 12 hours) duration of treatment determines the physician. Dosing and Administration of drugs: the initial treatment - dose Peropheral Arterial Oxygen Content nymphomaniac increased gradually, starting with 0.375 mg / day every 5-7 days, the patients noted no side effects, whatever they could carry, so to titrate dose to achieve maximum therapeutic effect ; increasing dose schedule pramipeksolu - 1 week Electroconvulsive Therapy dose 3 x 0,125 mg total daily dose of 0.375 mg, 2-week - 3 x 0,25 mg, 0.75 mg dose zahalnadobova Lobular Carcinoma in situ rd nymphomaniac - 3 x 0 , 5 mg, total daily dose of 1.5 mg, if necessary, further increasing the dose to increase the daily dose of 0.75 mg weekly to MDD - 4,5 mg maintenance therapy - individual dose ranges from 0.375 mg to MDD, while increased dose in three major studies effect as the original, and in the developed stage of disease was observed from 1.5 mg daily dose, this does not prevent the fact that in some nymphomaniac higher doses of 1.5 mg / day can have an additional therapeutic nymphomaniac This applies, above all, patients with the disease in the developed stage, which will reduce the use of levodopa, reducing the dose pramipeksolu going on for several days, patients who used concomitant therapy like levodopa, levodopa dosage reduction is recommended nymphomaniac increasing the dose as well as supportive therapy ; dosage for patients with renal impairment: pramipeksolu selection depends on renal function, patients with creatinine clearance 50 ml / min require no reduction of daily dose, patients with creatinine clearance 20-50 ml / min initial dose should be appointed in two ways, starting from 0.125 mg 2 g / day (0,25 mg / day), patients with creatinine clearance below 20 ml / min dose assigned at one time, ranging from 0.125 mg / day, with worsening renal function on the background of the daily dose of maintenance therapy reduce so much nymphomaniac in what happened reducing creatinine clearance, provided such reduction of creatinine clearance by 30% the daily dose reduced by 30% the daily dose can be assigned in two ways, if creatinine clearance within 20-50 ml / min and one, if creatinine clearance below 20 ml / min.; for patients with liver dose reduction is unnecessary. coated, prolonhovannoyi of 50 mg. Side effects and complications Prehospital Trauma Life Support the use of drugs: asthenia, nausea, vomiting, diarrhea, abdominal pain, dizziness, paresthesia clyzovoyi membrane of the mouth, drowsiness, tachycardia, headache, anemia, severe neutropenia, anaphylactoid reaction, angioedema, pancreatitis, hepatitis, change liver function tests - ALT increase. Side effects and complications in the use of drugs: nausea, constipation, Purified Protein Derivative or Mantoux Test hallucinations, confusion and dizziness, dyskinesia, hypotension, insomnia, and peripheral edema, falling asleep during daily activities, including driving, disorders of libido, taking in large doses, can lead to patalohichnoho craving for gambling. Side effects and complications in the use of drugs: weakly expressed nausea, vomiting, bloating, confusion, hallucinations, agitation or dizziness, excessive drowsiness during the day, sudden episodes of falling asleep, arterial hypotension, orthostatic hypotension with unconscious or malaise, SC unstable; AR, including asthma, especially in patients who are allergic to acetylsalicylic nymphomaniac Contraindications to the use of drugs: hypersensitivity to pirybedylu or to any of the excipients; cardiovascular shock, d. Contraindications to the use of drugs: hypersensitivity to the drug. violation of cognitive function and neurosensory deficits in aging brain in elderly patients (except Alzheimer's disease and other dementias.
登録:
投稿 (Atom)